These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22961455)

  • 1. Synthesis of insulin pump controllers from safety specifications using Bayesian model validation.
    Jha SK; Dutta RG; Langmead CJ; Jha S; Sassano E
    Int J Bioinform Res Appl; 2012; 8(3-4):263-85. PubMed ID: 22961455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mixed graphical models for simultaneous model identification and control applied to the glucose-insulin metabolism.
    Bleckert G; Oppel UG; Salzsieder E
    Comput Methods Programs Biomed; 1998 May; 56(2):141-55. PubMed ID: 9700429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop.
    Dassau E; Palerm CC; Zisser H; Buckingham BA; Jovanovic L; Doyle FJ
    Diabetes Technol Ther; 2009 Mar; 11(3):187-94. PubMed ID: 19191486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A framework for specifying safe behavior of the CIIP medical system.
    Babamir SM
    Adv Exp Med Biol; 2011; 696():637-44. PubMed ID: 21431605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Artificial neural networks for closed loop control of in silico and ad hoc type 1 diabetes.
    Fernandez de Canete J; Gonzalez-Perez S; Ramos-Diaz JC
    Comput Methods Programs Biomed; 2012 Apr; 106(1):55-66. PubMed ID: 22178070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Improved PID Algorithm Based on Insulin-on-Board Estimate for Blood Glucose Control with Type 1 Diabetes.
    Hu R; Li C
    Comput Math Methods Med; 2015; 2015():281589. PubMed ID: 26550021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Glucagon Action in Patients With Type 1 Diabetes.
    Emami A; Youssef JE; Rabasa-Lhoret R; Pineau J; Castle JR; Haidar A
    IEEE J Biomed Health Inform; 2017 Jul; 21(4):1163-1171. PubMed ID: 27448377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An insulin infusion advisory system based on autotuning nonlinear model-predictive control.
    Zarkogianni K; Vazeou A; Mougiakakou SG; Prountzou A; Nikita KS
    IEEE Trans Biomed Eng; 2011 Sep; 58(9):2467-77. PubMed ID: 21622071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymptotic tracking and disturbance rejection of the blood glucose regulation system.
    Ashley B; Liu W
    Math Biosci; 2017 Jul; 289():78-88. PubMed ID: 28495545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modelling endogenous insulin concentration in type 2 diabetes during closed-loop insulin delivery.
    Ruan Y; Thabit H; Wilinska ME; Hovorka R
    Biomed Eng Online; 2015 Mar; 14():19. PubMed ID: 25889091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A simulation model of glucose regulation in the critically ill.
    Hovorka R; Chassin LJ; Ellmerer M; Plank J; Wilinska ME
    Physiol Meas; 2008 Aug; 29(8):959-78. PubMed ID: 18641427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution modeling of nonlinear inverse controllers under a Bayesian framework.
    Herzallah R; Lowe D
    IEEE Trans Neural Netw; 2007 Jan; 18(1):107-14. PubMed ID: 17278465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin pump therapy.
    Rowe R
    Diabet Med; 2001 Nov; 18 Suppl 4():4-5. PubMed ID: 11989214
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of glucose controllers in virtual environment: methodology and sample application.
    Chassin LJ; Wilinska ME; Hovorka R
    Artif Intell Med; 2004 Nov; 32(3):171-81. PubMed ID: 15531149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New technologies in the treatment of type 1 diabetes.
    Schmidt S
    Dan Med J; 2013 Nov; 60(11):B4746. PubMed ID: 24192247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bolus calculator: a review of four "smart" insulin pumps.
    Zisser H; Robinson L; Bevier W; Dassau E; Ellingsen C; Doyle FJ; Jovanovic L
    Diabetes Technol Ther; 2008 Dec; 10(6):441-4. PubMed ID: 19049372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. To pump or not to pump.
    Schade DS; Wolpert H
    Diabetes Technol Ther; 2005 Oct; 7(5):845-8. PubMed ID: 16241896
    [No Abstract]   [Full Text] [Related]  

  • 18. Perioperative glycemic management in insulin pump patients undergoing noncardiac surgery.
    Abdelmalak B; Ibrahim M; Yared JP; Modic MB; Nasr C
    Curr Pharm Des; 2012; 18(38):6204-14. PubMed ID: 22762462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of insulin pump therapy based on high order run-to-run control scheme.
    Tuo J; Sun H; Shen D; Wang H; Wang Y
    Comput Methods Programs Biomed; 2015 Jul; 120(3):123-34. PubMed ID: 25981797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin pump therapy guidelines for China (July 2010).
    Mu Y; Yin S;
    J Diabetes; 2012 Jun; 4(2):127-39. PubMed ID: 22107806
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.